BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 27512055)

  • 1. Antigenic Fingerprinting of Antibody Response in Humans following Exposure to Highly Pathogenic H7N7 Avian Influenza Virus: Evidence for Anti-PA-X Antibodies.
    Khurana S; Chung KY; Coyle EM; Meijer A; Golding H
    J Virol; 2016 Oct; 90(20):9383-93. PubMed ID: 27512055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.
    Khurana S; Chearwae W; Castellino F; Manischewitz J; King LR; Honorkiewicz A; Rock MT; Edwards KM; Del Giudice G; Rappuoli R; Golding H
    Sci Transl Med; 2010 Jan; 2(15):15ra5. PubMed ID: 20371470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific memory B cell response in humans upon infection with highly pathogenic H7N7 avian influenza virus.
    Westerhuis B; Ten Hulscher H; Jacobi R; van Beek J; Koopmans M; Rimmelzwaan G; Meijer A; van Binnendijk R
    Sci Rep; 2020 Feb; 10(1):3152. PubMed ID: 32081953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans.
    Chung KY; Coyle EM; Jani D; King LR; Bhardwaj R; Fries L; Smith G; Glenn G; Golding H; Khurana S
    Vaccine; 2015 Jul; 33(32):3953-62. PubMed ID: 26093202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets.
    Khurana S; Suguitan AL; Rivera Y; Simmons CP; Lanzavecchia A; Sallusto F; Manischewitz J; King LR; Subbarao K; Golding H
    PLoS Med; 2009 Apr; 6(4):e1000049. PubMed ID: 19381279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of avian influenza virus diversity in poultry and humans during a highly pathogenic avian influenza A (H7N7) virus outbreak.
    Jonges M; Bataille A; Enserink R; Meijer A; Fouchier RA; Stegeman A; Koch G; Koopmans M
    J Virol; 2011 Oct; 85(20):10598-604. PubMed ID: 21849451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine.
    Khurana S; Coyle EM; Verma S; King LR; Manischewitz J; Crevar CJ; Carter DM; Ross TM; Golding H
    Vaccine; 2014 Nov; 32(48):6421-32. PubMed ID: 25284811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of antibodies to avian influenza virus A(H7N7) in humans by hemagglutination inhibition test.
    Meijer A; Bosman A; van de Kamp EE; Wilbrink B; Du Ry van Beest Holle M; Koopmans M
    J Virol Methods; 2006 Mar; 132(1-2):113-20. PubMed ID: 16271401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antigenic architecture of the hemagglutinin of influenza H5N1 viruses.
    Velkov T; Ong C; Baker MA; Kim H; Li J; Nation RL; Huang JX; Cooper MA; Rockman S
    Mol Immunol; 2013 Dec; 56(4):705-19. PubMed ID: 23933511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans.
    Khurana S; Wu J; Verma N; Verma S; Raghunandan R; Manischewitz J; King LR; Kpamegan E; Pincus S; Smith G; Glenn G; Golding H
    J Virol; 2011 Nov; 85(21):10945-54. PubMed ID: 21865396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino Acid Substitutions Improve the Immunogenicity of H7N7HA Protein and Protect Mice against Lethal H7N7 Viral Challenge.
    Kumar SR; Prabakaran M; Ashok Raj KV; He F; Kwang J
    PLoS One; 2015; 10(6):e0128940. PubMed ID: 26030920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal immunization of baculovirus displayed hemagglutinin confers complete protection against mouse adapted highly pathogenic H7N7 reassortant influenza virus.
    Rajesh Kumar S; Syed Khader SM; Kiener TK; Szyporta M; Kwang J
    PLoS One; 2013; 8(6):e63856. PubMed ID: 23762234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice.
    Wohlbold TJ; Chromikova V; Tan GS; Meade P; Amanat F; Comella P; Hirsh A; Krammer F
    J Virol; 2016 Jan; 90(2):851-61. PubMed ID: 26512088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands.
    Koopmans M; Wilbrink B; Conyn M; Natrop G; van der Nat H; Vennema H; Meijer A; van Steenbergen J; Fouchier R; Osterhaus A; Bosman A
    Lancet; 2004 Feb; 363(9409):587-93. PubMed ID: 14987882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in young adults and children.
    Verma N; Dimitrova M; Carter DM; Crevar CJ; Ross TM; Golding H; Khurana S
    J Virol; 2012 May; 86(10):5515-22. PubMed ID: 22379097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys.
    Min JY; Vogel L; Matsuoka Y; Lu B; Swayne D; Jin H; Kemble G; Subbarao K
    J Virol; 2010 Nov; 84(22):11950-60. PubMed ID: 20810733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cross-sectional serological survey of the Dutch commercial poultry population for the presence of low pathogenic avian influenza virus infections.
    de Wit JJ; Koch G; Fabri TH; Elbers AR
    Avian Pathol; 2004 Dec; 33(6):565-70. PubMed ID: 15763723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanisms.
    Tan Y; Ng Q; Jia Q; Kwang J; He F
    J Virol; 2015 Apr; 89(7):3712-22. PubMed ID: 25609802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.